Eureka Therapeutics pursues innovations that will change the world. We develop technologies that advance the field of antibody therapeutics by increasing the efficacy and specificity of antibody drugs, and the expression level of antibody cell lines. Eureka also provides a wide array of contract research services available to other companies. These services center around cell line development and antibody production or purification.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Eureka Therapeutics or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.